Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  oncolytic HSV-1716
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Oncolytic HSV1716 in Treating Patients with Refractory Non-Central Nervous System Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 13 to 30
Trial IDs: OSU-08196, NCI-2016-00251, IRB13-00471, NCT00931931
Oncolytic HSV-1716 in Treating Younger Patients with Refractory or Recurrent High Grade Glioma That Can Be Removed by Surgery
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 to 21
Trial IDs: PBTC-037, NCI-2013-00526, NCT02031965
Start Over